Group A Streptococcus vaccine
A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Europäisches Patentamt - (2019) vom: 28. Mai Zur Gesamtaufnahme - year:2019 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
PANDEY MANISHA [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019-05-28, Last update posted on www.tib.eu: 2024-04-24, Last updated: 2024-05-03 |
---|
Patentnummer: |
US10301362 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA00389990X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA00389990X | ||
003 | DE-627 | ||
005 | 20240503111325.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240426s2019 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA00389990X | ||
035 | |a (EPA)US10301362 | ||
035 | |a (EPA)54323282 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a PANDEY MANISHA |e verfasserin |4 aut | |
245 | 1 | 0 | |a Group A Streptococcus vaccine |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2019-05-28, Last update posted on www.tib.eu: 2024-04-24, Last updated: 2024-05-03 | ||
520 | |a A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a BATZLOFF MICHAEL |e verfasserin |4 aut | |
700 | 0 | |a GOOD MICHAEL |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2019) vom: 28. Mai |
773 | 1 | 8 | |g year:2019 |g day:28 |g month:05 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/54323282/publication/US10301362A1?q=US10301362 |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2019 |b 28 |c 05 |